Science Explorer Back to mapMap

Most cited papers from Karl Landsteiner Society

What are the most cited papers from Karl Landsteiner Society?

The most cited paper from Karl Landsteiner Society is "Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018)" (Jean‐Pascal Lefaucheur et al., 2019), with 2,413 citations. Next come "Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial" (2,310) and "Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review" (1,011).

Showing 50 of 60 papers. Every paper with more than 114 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018) Jean‐Pascal Lefaucheur et al. · Clinical Neurophysiology Open access 31 Dec 2019 2,413
2 Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial Luis G Paz-Ares et al. · The Lancet 246 authors 4 Oct 2019 2,310
3 Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review Klaus Seppi, К. Ray Chaudhuri, Miguel M Coelho et al. · Movement Disorders Open access 17 Jan 2019 1,011
4 Persistent immune activation in HIV-1 infection is associated with progression to AIDS Mette D. Hazenberg, Sigrid A. Otto, Birgit HB van Benthem et al. · AIDS 27 Aug 2003 786
5 Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial Jonathan Wade Goldman et al. · The Lancet Oncology Open access253 authors 4 Dec 2020 707
6 Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial Bernhard H. Ludvik, Francesco Giorgino, Esteban Jódar et al. · The Lancet Aug 2021 628
7 The O nset of N onmotor S ymptoms in P arkinson's disease ( T he ONSET PD S tudy) Claustre Pont‐Sunyer et al. · Movement Disorders Dec 2014 512
8 Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism Sabine Eichinger, Georg Heinze, Lisanne M. Jandeck et al. · Circulation 30 Mar 2010 508
9 Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC) Francesco Soria, Shahrokh François Shariat, Seth P. Lerner et al. · World Journal of Urology Open access 7 Sep 2016 485
10 A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes Bernhard Paulweber et al. · Hormone and Metabolic Research Open access129 authors Apr 2010 481
11 Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial Thomas Sonnweber et al. · European Respiratory Journal Open access 10 Dec 2020 452
12 European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017 Franz Trautinger, Johanna Eder, Chalid Assaf et al. · European Journal of Cancer Open access 31 Mar 2017 452
13 Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders Simone Mader, Viktoria Gredler, Kathrin Schanda et al. · Journal of Neuroinflammation Open access Dec 2011 451
14 Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance Michael Roden · Nature Clinical Practice Endocrinology &#38 Metabolism Jun 2006 409
15 Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals Stefanie Theresa Jost et al. · Movement Disorders ReviewOpen access 5 May 2023 390
16 Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN Luis G Paz-Ares et al. · ESMO Open Open access 10 Mar 2022 349
17 Effectiveness of Progressive Muscle Relaxation, Deep Breathing, and Guided Imagery in Promoting Psychological and Physiological States of Relaxation Loren L. Toussaint, Quang Anh Nguyen, Claire Roettger et al. · Evidence-based Complementary and Alternative Medicine Open access 2 Jul 2021 325
18 European Society of Anaesthesiology and European Board of Anaesthesiology guidelines for procedural sedation and analgesia in adults Jochen Hinkelbein, Massimo Lamperti, Jonas Åkeson et al. · European Journal of Anaesthesiology Open access 6 Sep 2017 317
19 Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial (cMPsE02) Sebastian Bauer, Hartmut Baier, Christian Baumgärtner et al. · Brain stimulation Open access 21 Jan 2016 281
20 Macrophages eliminate circulating tumor cells after monoclonal antibody therapy Nuray Gül, Liane Babes, Kerstin Siegmund et al. · Journal of Clinical Investigation Open access 15 Jan 2014 276
21 Risk assessment for recurrent venous thrombosis Paul Alexander Kyrle, Frits Richard Rosendaal, Sabine Eichinger · The Lancet Dec 2010 264
22 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases James M. Gwinnutt, Maud Wieczorek, Andra Rodica Balanescu et al. · Annals of the Rheumatic Diseases Open access 8 Mar 2022 262
23 An immunoepidemiological approach to asthma: identification of in-vitro T cell response patterns associated with different wheezing phenotypes in children Tricia Heaton, Julie Rowe, Steve Turner et al. · The Lancet Open access 2005 257
24 Muscle Mitochondrial ATP Synthesis and Glucose Transport/Phosphorylation in Type 2 Diabetes Julia Szendroedi, Albrecht Ingo Schmid, Marek Chmelík et al. · PLoS Medicine Open access 26 Apr 2007 247
25 Take Action to Prevent Diabetes – The IMAGE Toolkit for the Prevention of Type 2 Diabetes in Europe Jaana Lindström et al. · Hormone and Metabolic Research Open access108 authors Apr 2010 239
26 Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes Albrecht Ingo Schmid, Julia Szendroedi, Marek Chmelík et al. · Diabetes Care Open access 8 Jan 2011 217
27 MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation Jean Bousquet et al. · Allergy Open access263 authors 4 Jul 2015 205
28 Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation Kirsten M. L. Hertoghs, Perry D. Moerland, Amber van Stijn et al. · Journal of Clinical Investigation Open access Oct 2010 201
29 The Impact of Vitamin D, Calcium, Protein Supplementation, and Physical Exercise on Bone Metabolism After Bariatric Surgery: The BABS Study Christian Muschitz, Roland Kocijan, Judith Haschka et al. · Journal of Bone and Mineral Research 9 Sep 2015 199
30 Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling Annika De Sousa Linhares, Claire Battin, Sabrina Jutz et al. · Scientific Reports Open access 7 Aug 2019 198
31 Beneficial effects of multi-disciplinary rehabilitation in postacute COVID-19: an observational cohort study Bernhard Puchner, Sabina Sahanic, Rudolf Kirchmair et al. · European Journal of Physical and Rehabilitation Medicine May 2021 186
32 Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients’ performance: a prospective observational cohort study Thomas Sonnweber et al. · Respiratory Research Open access 21 Oct 2020 185
33 To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis Ram Benny Dessau, Alje Pieter van Dam, Volker Fingerle et al. · Clinical Microbiology and Infection Open access 5 Sep 2017 180
34 Intravenous fosfomycin—back to the future. Systematic review and meta-analysis of the clinical literature Béatrice Grabein, Winfried B. Graninger, Jesús Rodríguez‐Baño et al. · Clinical Microbiology and Infection ReviewOpen access 9 Dec 2016 177
35 Risk of Rupture of Small Anterior Communicating Artery Aneurysms Is Similar to Posterior Circulation Aneurysms Philippe Bijlenga et al. · Stroke Open access111 authors 31 Jul 2013 165
36 Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial Marc P. Bonaca, Andrei‐Mircea Catarig, Kim Christian Houlind et al. · The Lancet 31 Mar 2025 157
37 The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review Mohammad M. Abufaraj, Guido M. Dalbagni, Siamak Daneshmand et al. · European Urology ReviewOpen access 7 Nov 2017 150
38 Extent and Clinical Consequences of Antibody Formation Against Adalimumab in Patients With Plaque Psoriasis Lidian L. A. Lecluse, R.J.B. Driessen, Phyllis Ira Spuls et al. · Archives of Dermatology Open access Feb 2010 150
39 Premature senescence of endothelial cells upon chronic exposure to TNFα can be prevented by N-acetyl cysteine and plumericin Shafaat Yar Khan, Ezzat Mohamed Awad, André Oszwald et al. · Scientific Reports Open access 3 Jan 2017 147
40 Occupational risk factors for osteoarthritis of the knee: a meta-analysis Daniel F. McWilliams, Burkhard F. Leeb, Stella G. Muthuri et al. · Osteoarthritis and Cartilage ReviewOpen access 7 Mar 2011 147
41 An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer Francesco Soria, Michael J. Droller, Yair Lotan et al. · World Journal of Urology Open access 21 Jun 2018 143
42 Anti‐contactin‐associated protein‐2 encephalitis: relevance of antibody titres, presentation and outcome Christian G. Bien, Zulfiya Mirzadjanova, Christoph Baumgartner et al. · European Journal of Neurology 27 Oct 2016 143
43 First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis Fahad Quhal, Keiichiro Mori, Andreas Bruchbacher et al. · European Urology Oncology Review 20 Mar 2021 142
44 Seizure detection using scalp‐ EEG Christoph Baumgartner, Johannes Peter Koren · Epilepsia Jun 2018 139
45 Protection against Renal Ischemia Reperfusion Injury by CD44 Disruption Kasper M. A. Rouschop, Joris J. T. H. Roelofs, Nike Claessen et al. · Journal of the American Society of Nephrology 18 May 2005 139
46 Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis Florian Janisch, Shahrokh François Shariat, Pascal Baltzer et al. · World Journal of Urology Review 18 Jul 2019 138
47 Assessment of 31P relaxation times in the human calf muscle: A comparison between 3 T and 7 T in vivo Wolfgang Bogner, Marek Chmelík, Albrecht Ingo Schmid et al. · Magnetic Resonance in Medicine Open access 12 Jun 2009 137
48 Towards a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: communication from the SSC of the ISTH Charlotte E. A. Dronkers, Tom van der Hulle, Grégoire Le Gal et al. · Journal of Thrombosis and Haemostasis Open access 15 Feb 2017 127
49 Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns—Results of a non-interventional study of the DeCOG Uwe Hillen et al. · European Journal of Cancer 14 Apr 2018 125
50 Accuracy of machine learning classifiers using bilateral data from a Scheimpflug camera for identifying eyes with preclinical signs of keratoconus Illés Kovács, Kata Miháltz, Kinga Kránitz et al. · Journal of Cataract & Refractive Surgery Feb 2016 124

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.